Join industry thought leaders from Integra Connect and Thermo Fisher on Thursday, November 16 at 12:00pm EST | 9:00am PST. November is Lung Cancer Awareness Month. While providers understand the growing role of genetics and genomics especially in cancer care, experts agree that genomic testing in discovery and treatment is still at the precipice and in need of greater adoption within the practice to accelerate initiatives and achieve better personalized medicine for patients.
During this session, experts will discuss:
What are the latest trends and updates in the genomic landscape?
What are the barriers that still exist in genomic testing for cancer care? What solutions could be implemented to address these barriers?
What recent ASCO research has been done in genomics with Thermo Fisher and RWE? Why was this research important?
What are some best practices to drive improvement in and around genomics at the point of care and beyond?
Jeffrey Scott, MD
Chief Medical Officer & President of Population Health at Integra Connect
Value-based care models are increasingly incentivizing providers to demonstrate high-quality care at lower costs. While providers need to understand and track the most effective quality measures to...
The annual ASCO scientific meeting never fails to inform, educate and spur conversation -- from new data focused on treatment approaches, discussions related to gaps in care or innovations designed...
Hear FIERCE Biotech's webinar featuring Integra Connect. Many life sciences companies are turning to real-world data for their research and commercialization efforts and to make more informed...